4528 (4528) News
Follow 4528 (4528) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Ono Pharmaceutical Reports First-Half Net Profit Above Prior Year
Ono Pharmaceutical reported higher first-half net profit and operating profit year over year, while revenue declined.
EARNINGS | Oct 29, 2026, 03:00 AM UTC
M
Bristol Myers, Ono sue Amgen to block Opdivo biosimilar
Bristol Myers Squibb and Ono Pharmaceutical sued Amgen in Delaware federal court seeking to block Amgen’s proposed U.S. biosimilar of Opdivo.
EQUITY | Sep 15, 2026, 08:25 PM UTC
L
Bristol Myers sues Amgen over proposed Opdivo biosimilar
By Blake BrittainBristol Myers Squibb NYSE:BMY and Ono Pharmaceutical TSE:4528 have sued Amgen NASDAQ:AMGN in Delaware federal court, seeking to block Amgen's proposed U.S. biosimilar of their blockbuster cancer immunoth
NEWS | Sep 15, 2026, 05:29 PM UTC